Elevated MMP-9 levels in cerebrospinal fluid and plasma are consistently associated with hemorrhagic transformation following thrombolytic therapy in stroke, highlighting its dual significance as both a mechanistic driver of vascular injury and a clinically relevant biomarker [32]. This evidence concerns the gene MMP9 and stroke disorder.